Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial

Autor: Davids, Matthew S *, Brander, Danielle M, Kim, Haesook T, Tyekucheva, Svitlana, Bsat, Jad, Savell, Alexandra, Hellman, Jeffrey M, Bazemore, Josie, Francoeur, Karen, Alencar, Alvaro, Shune, Leyla, Omaira, Mohammad, Jacobson, Caron A, Armand, Philippe, Ng, Samuel, Crombie, Jennifer, LaCasce, Ann S, Arnason, Jon, Hochberg, Ephraim P, Takvorian, Ronald W, Abramson, Jeremy S, Fisher, David C, Brown, Jennifer R
Zdroj: In The Lancet Haematology August 2019 6(8):e419-e428
Databáze: ScienceDirect